Petrini M - Search Results

1

Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.

Massaro F, Stepanishyna Y, Manni M, Luminari S, Galimberti S, Marcheselli L, Visco C, Tecchio C, Stelitano C, Angrilli F, Petrini M, Merli F, Federico M. Massaro F, et al. Among authors: petrini m. Br J Haematol. 2021 Mar;192(6):1011-1014. doi: 10.1111/bjh.16714. Epub 2020 May 14. Br J Haematol. 2021. PMID: 32410259 Free article. Clinical Trial.

2

Alternating chemotherapy regimen (P-VABEC) for intermediate and high-grade non-Hodgkin's lymphoma of the middle aged and elderly.

Caracciolo F, Petrini M, Capochiani E, Papineschi F, Carulli G, Grassi B. Caracciolo F, et al. Among authors: petrini m. Hematol Oncol. 1994 Jul-Aug;12(4):185-92. doi: 10.1002/hon.2900120405. Hematol Oncol. 1994. PMID: 7528162 Clinical Trial.

3

Biological effects of PEMF (pulsing electromagnetic field): an attempt to modify cell resistance to anticancer agents.

Pasquinelli P, Petrini M, Mattii L, Galimberti S, Saviozzi M, Malvaldi G. Pasquinelli P, et al. Among authors: petrini m. J Environ Pathol Toxicol Oncol. 1993 Oct-Dec;12(4):193-7. J Environ Pathol Toxicol Oncol. 1993. PMID: 8189374

4

Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient.

Petrini M, Conte A, Caracciolo F, Sabbatini A, Grassi B, Ronca G. Petrini M, et al. Br J Haematol. 1993 Oct;85(2):409-10. doi: 10.1111/j.1365-2141.1993.tb03187.x. Br J Haematol. 1993. PMID: 8280615

5

c-Jun and GST-pi expression in human plasma cells.

Di Simone D, Galimberti S, Mattii L, Petrini M. Di Simone D, et al. Among authors: petrini m. Haematologica. 1997 Jan-Feb;82(1):69-70. Haematologica. 1997. PMID: 9107087

6

c-Ha-ras transfection and expression of MDR-related genes in MCF-10A human breast cell line.

Di Simone D, Galimberti S, Basolo F, Ciardiello F, Petrini M, Scheper RJ. Di Simone D, et al. Among authors: petrini m. Anticancer Res. 1997 Sep-Oct;17(5A):3587-92. Anticancer Res. 1997. PMID: 9413207

7

[Treatment of multidrug resistance in oncology and hematology].

Petrini M, Galimberti S. Petrini M, et al. Tumori. 1997 Sep-Oct;83(5 Suppl):S17-20. Tumori. 1997. PMID: 9446254 Italian.

8

Multidrug resistance related genes and p53 expression in human non small cell lung cancer.

Galimberti S, Marchetti A, Buttitta F, Carnicelli V, Pellegrini S, Bevilacqua G, Petrini M. Galimberti S, et al. Among authors: petrini m. Anticancer Res. 1998 Jul-Aug;18(4C):2973-6. Anticancer Res. 1998. PMID: 9713494

9

Clinical characteristics, treatment outcome and survival of 36 adult patients with primary anaplastic large cell lymphoma. Gruppo Italiano per lo Studio dei Linfomi (GISL).

Longo G, Fiorani C, Sacchi S, Callea V, Lombardo M, Federico M, Stelitano C, Angrilli F, Vallisa D, Gobbi PG, Ilariucci F, Frassoldati A, Petrini M, Silingardi V. Longo G, et al. Among authors: petrini m. Haematologica. 1999 May;84(5):425-30. Haematologica. 1999. PMID: 10329921 Free article. Clinical Trial.

10

Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia.

Galimberti S, Papineschi F, Carmignani A, Testi R, Fazzi R, Petrini M. Galimberti S, et al. Among authors: petrini m. Bone Marrow Transplant. 1999 Aug;24(3):345-8. doi: 10.1038/sj.bmt.1701875. Bone Marrow Transplant. 1999. PMID: 10455379

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

766 results

Search Page